Refine Results
- 必威体育赛事投注
- Content Type
- Analysis Platform
- Language
21 - 32 of 32 results
Applied Filters
In the pharmaceutical industry, the regulatory requirements towards paperless operation become the driving force towards digitalization transformation.In this study, a small-scale analytical laboratory was configured to emulate a biopharmaceutical...
This document serves as an overview for customers interested in moving their analytical data systems to a cloud service provider.The reader should be familiar with the cloud solutions offered by Amazon and Microsoft.
This technical note describes how one of the largest pharmaceutical companies utilized Custom Calculator for OpenLab CDS to save their lab hours per day and eliminate painful and time-consuming manual steps previously required of their lab analysts.
Do you need an extra level of resolution and confidence in your analyses?Discover our powerful solutions for two-dimensional liquid chromatography (2D-LC).
必威体育登录手机This white paper is a resource for users of Agilent OpenLab CDS version 2.8 whose organizations must comply with US FDA Part 11 in Title 21 of the Code of Federal Regulations (CFR), and its EU analog, Eudralex Chapter 4, Annex 11.
必威体育登录手机This white paper explores how Agilent Sample Scheduler for OpenLab streamlines sample analysis and manages the analytical workload of a laboratory.
To ensure maximum performance and productivity, it's important to upgrade your lab's chromatography data systems (CDS).Read on for answers to 10 common questions about the process of a CDS upgrade.
This scientific poster presents a prototype application that addresses pain points in generic data extraction methods.It demonstrates how to eliminate manual file manipulation by implementing a relational database to track chromatography...
OpenLab CDS focuses on routine analysis workflows in the pharma and chemical and energy quality control markets.Labs often perform various analyses, some of which are supported by OpenLab CDS while others are not.This white paper explains the...
必威体育登录手机This white paper is a resource for users of Agilent OpenLab ChemStation systems whose organizations must comply with US FDA Part 11 in Title 21 of the Code of Regulations (CFR), and its EU analog, Eudralex Chapter 4, Annex 11, requirements.
本技術說明描述了某一大型製藥公司如何利用 OpenLab CDS 自定義計算器來節省日常實驗室時間,並免去實驗室分析人員過去需要進行的困難且耗時的手動步驟。
必威体育登录手机本白皮書為自身組織必須符合 US FDA 21 CFR Part 11（美國聯邦法規第 21 章第 11 款）及其類似條款歐盟 Eudralex 第 4 章附錄 11 要求的 Agilent OpenLab ChemStation 係統的用戶提供了有用的資源。